Tag Archives: U.S. Preventive Services Task Force

STD Awareness: HPV Testing vs. the Pap Test

Posted on by

I love writing about health and medicine, but I hate going to the doctor. I don’t like taking my clothes off for a dermatological exam, I don’t like rolling my sleeve up for a shot, and I don’t like opening my mouth for a dentist. I don’t even like having my blood pressure taken — it gives me the heebie-jeebies, and probably a case of white-coat hypertension too.

For now, pelvic exams are a mainstay — and an important part of cancer prevention.

So when it comes to something even more invasive, like the Pap test to screen for cervical cancer, I’m one of those people pining for a magic wand — a tool that a health care provider can wave over your fully clothed body to detect disease. The Pap test may have transformed a scourge like cervical cancer into one of the most easily detected and treated cancers — and for that I love it — but I still fervently wish for its demise. As long as it’s replaced by something better, of course.

Last month, an article in JAMA inspired a burst of headlines. “HPV test more effective than Pap smear in cancer screening,” said CNN. Or as WebMD put it more succinctly, “HPV Test Beats Pap.” Then, last week, the U.S. Preventive Services Task Force updated their guidelines to recommend that patients 30 and older can forgo the Pap test in favor of HPV testing alone. This news might be welcome to anyone who dislikes regular Pap tests and wishes to avoid stirrups and speculums. Unfortunately, HPV tests aren’t the noninvasive “magic wand” so many of us hope for. From the patient’s perspective, the experience of undergoing an HPV test is no different from the experience of undergoing a Pap test. They both require a pelvic exam — the stuff of stirrups and speculums. Continue reading →

Some Good News About Three Sexually Transmitted Viruses

Posted on by

Scientists are hard at work finding ways to improve your health!

With so much bad news emblazoned across headlines in every newspaper you look at, the world might seem like a gloomy place. So let’s take one depressing subject — disease — and peel away the sad outer layer to find silver linings of optimism.

When it comes to infections, a lot of us blame one thing: germs, also known as “bugs” — “pathogens” if we’re fancy. Some people might not think of infectious diseases as being that big of a deal — after a round of antibiotics, you’ll be on the mend. Unfortunately, antibiotics only work for bacteria, but a lot of diseases are caused by other types of germs — for which antibiotics are no match. One type of germ is called a virus, and they can’t be cured. Sometimes they can be prevented with vaccines or treated with drugs. For example, the major strains of human papillomavirus (HPV) can be prevented with a vaccine called Gardasil, herpes simplex virus can be suppressed with antiviral drugs, and HIV can be controlled with antiretroviral drugs — but none of these infections can be cured. HPV is usually defeated by the immune system, but herpes and HIV are with you for life.

But it’s not all bad. Around the world, individual scientists have picked their “favorite” viruses and are devoting their lives to finding better prevention strategies, better treatments, and even cures. Let’s check in with some of the latest headlines touting the successes of science.

New Hope for a Herpes Vaccine

A herpes vaccine would be a blockbuster — given how common this sexually transmitted infection is, a preventive shot could help a lot of couples discuss their herpes status without as much fear of judgment and stigma.

Herpes might cause an “outbreak” — unpleasant symptoms that include genital sores — but afterward the virus goes dormant in the nerve cells, hiding from the immune system. In some people, the virus can come out of its dormancy to cause flare-ups of symptoms, but once it’s had its fun it retreats back to the nerve cells.

Earlier this year, media reported on a promising new candidate for a herpes vaccine. Using a completely different strategy than previous, failed herpes vaccines, the researchers behind this breakthrough targeted the part of the virus that allows it to hide from our immune systems. If this vaccine works as hoped, recipients will be able to mount an immune defense when exposed to the virus, blocking it from establishing a permanent home in nerve cells. It might even suppress outbreaks in people who already have herpes. Continue reading →

To Mammography or Not

Posted on by

The following guest post comes to us via Cynthia.

questionOctober is probably one of the best examples of a public awareness campaign catching on and sticking. Maybe you already knew, thanks to the ubiquitous pink ribbons you see all around you this month, but October is National Breast Cancer Awareness Month, a time to encourage people to receive screening for the most common cancer among American women. The movement to promote breast cancer awareness has become pervasive. But for me, breast cancer is more than just a campaign — it is a disease that has become a part of my family history. And it has become personal, with numerous friends diagnosed and getting treatment, some of them before they reached the age of 35.

Contradictions regarding mammography exist within the medical community. Where did all of this put me?

When I turned 30, I talked to my doctor about my family history and the concerns I had about breast cancer. Although most health experts don’t recommend a mammography until a woman is in her 40s or 50s, she provided me with a referral to get a mammogram so that we had a baseline image for future comparison. I was anxious while I sat in the waiting room at the imaging center, but I also felt like I was being responsible and proactive when it came to my health. The mammogram was normal and it was put into my file. It wouldn’t be looked at again until I was 40, when my ob/gyn recommended that I get my next mammogram.

This October isn’t just Breast Cancer Awareness Month. It’s also the month I turned 40. I am preparing for my next mammogram, but I have questions for my doctor before I make the appointment. Is it really necessary? Can I wait to get my next mammogram? I have a lot of questions, because there was conflicting information handed down earlier this year from the U.S. Preventive Services Task Force. Continue reading →

Over 90 Percent of What Planned Parenthood Does, Part 19: Prostate Exams for Cancer Screening

Posted on by

prostateWelcome to the latest installment of “Over 90 Percent of What Planned Parenthood Does,” a series on Planned Parenthood Advocates of Arizona’s blog that highlights Planned Parenthood’s diverse array of services — the ones Jon Kyl never knew about.

It’s Prostate Cancer Awareness Month. This type of cancer strikes 1 out of 5 Americans with prostates. There are two common screening tests for it — and Planned Parenthood Arizona offers both of them. The first test, and the subject of this post, is the prostate exam. The second is the prostate specific antigen (PSA) test — which has both benefits and drawbacks, and which will be the subject of a future post.

Here’s the good news/bad news: Prostate cancer is the second-leading cause of men’s cancer deaths, but it also has very high survival rates when detected and treated early — a five-year survival rate of almost 100 percent.

What’s a prostate?

A normal prostate is a one-ounce, walnut-sized gland that is part of the male reproductive system. It manufactures fluid that is mixed with sperm to create semen, which is the product of ejaculation. However, the gland can often enlarge, especially later in life. Since the prostate is nestled right in there with the bladder and the urethra, when it grows in size it can block the flow of urine (it can also cause sexual problems). An enlarged prostate, also called benign prostatic hyperplasia (BPH), can mimic the symptoms of prostate cancer — but it’s not cancer. It may be treated surgically, however.

Am I at risk for prostate cancer?

While prostate cancer is common, there are a few factors that can increase your risk even more. These include:

  • age (two-thirds of prostate cancers occur in people 65 years of age or older)
  • genetics (a family history of prostate cancer — especially if a father or brother developed prostate cancer before the age of 65)
  • being of African-American descent (prostate cancer is more common in African Americans than in Americans of other races) Continue reading →

How Often Do I Need a Pap Test?

Posted on by

Editor’s Note: In August 2018, the U.S. Preventive Services Task Force updated their recommendations to allow patients 30 to 65 years of age to receive HPV testing alone every five years — without an additional Pap test.

Almost 80 years ago, Dr. George Papanicolaou developed a simple test, the Pap test (also called the Pap smear), done in a doctor’s office to check for cervical cancer. During a pelvic exam, a doctor swabs a small sample of cervical tissue and looks for abnormal cells. If these precancerous cells are detected, it will lead to more tests or other more invasive treatments such as a colposcopy (in which actual tissue may be removed). In the 1930s, when Papanicolaou was developing his test, cervical cancer was more lethal than breast cancer. But since the development of this test, the number of women dying from cervical cancer has dropped dramatically. In 2009, of the 4,000 women in the United States who died of cervical cancer, most had never been screened or had not been screened in the 10 years before their diagnosis.

This year, the U.S. Preventive Services Task Force recommended less frequent Pap testing.

Cervical cancer is most common in women between ages 35 and 55, and usually develops from a human papillomavirus or HPV infection. Not all HPV infections lead to cervical cancer, and it can take decades for a persistent infection with a high-risk type of HPV to become cancer. High-risk HPV types are sexually transmitted and can lead to cervical cancer and also anal, penile, and oral cancers.

There are two types of screening: Pap tests and HPV tests. While they both require a pelvic exam in which cells are taken from the cervix, Pap tests look for abnormal or precancerous cells, and HPV tests look for DNA or RNA from high-risk HPV types in cervical cells. Both tests are used to try to catch cervical cancer in its earliest stages so that it can be successfully treated. Continue reading →